HelpHelp About Us Contact Contact Us Help Help
Press Release Service
user name password
Client login:   
First time user sign up Forgot your login info?
Website Directory     Submit Website

Search
EmailWire News Links

Home > News By Company > DailyDose Weight

Print e mail rss del Y! myWeb Tweet
 

Generic Drugs Challenge the American Pharmaceutical Industry

Generic drug makers are making drugs as safe as American pharmaceutical companies and selling them at 1/20th of the American price.

(EMAILWIRE.COM, February 11, 2010 ) As more people are relying on prescription drugs and other over the counter medications, American pharmaceutical companies have been capitalizing with high price tags on their products. However, in recent years, this stranglehold on the pharmaceutical market has been challenged by an unlikely source: India.

A number of Indian drug manufacturers specialize in quality generic drugs. Generic drugs are an important alternative to name brand options, offering the same medication, but at a lesser price.

One of the drug companies currently making a significant impact on American markets is Cipla. This India-based company has thrived in recent years, working with the world's largest pharmaceutical companies to make palpable inroads with Western consumers. Cipla has met FDA standards with its many drug options, guaranteeing the safety and quality of the products for the American public.

Though it produces many pharmaceutical products, Cipla has gained the most attention for its generic Viagra products. These drugs are generic equivalents to the popular Erectile Dysfunction drug, and have been sought by men of all ages who are suffering from ED issues. The Cipla generic options have been proven to be as safe and effective as the original, easily pleasing the increasingly large market for such products.

While the safety and efficacy of Cipla's products are important, those factors are not the only reasons why Cipla is such a major player in the pharmaceutical world. In contrast to name brand drugs such as Viagra, Cipla's generic alternatives are available at a fraction of the price. In fact, most of Cipla's drug selections can be purchased at 1/20th of the cost. For example, its generic cialis pills each cost approximately $1 as opposed to $20 here in the U.S. This dramatic price reduction not only makes these products more widely available to the public, but they also put free market pressure on name brand providers to lower their prices in order to stay competitive.

Interested consumers can talk to their doctor or pharmacists about the various generic drugs carried by Cipla or other Indian drug manufacturers. It is also possible to pursue these options online in order to better compare and contrast the products. There are a number of reputable websites that offer detailed information and ordering opportunities.

For individuals particularly interested in learning more about the various generic options for ED treatment, one such site is http://www.genericviagra.net . This fantastic resource is geared toward education and treatment, with a wonderful selection of generic drugs to help make the decision to get help even easier.

Contact Information:
DailyDose Weight
Francis Goldemberg
Tel: 2123754224
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International

Equityallianceir.com





Penny Stocks to Watch

Sign up for hot penny stock picks
Gains of 500%+ possible!

Premiumstockpicks.com/landing/




Your text Ads & 

PR

Text Ads plus unlimited press releases, One release featured/Day for only $575 per month.

Read more on Text Ads & PR






Your text Ads Here!

Text Ads are only $289 per month. Ads are placed same day.

More on Text Ads Advertising



 

Search


Advertising | How to contact us | Privacy Statement | EmailWire Press Releases | Partnership Opportunities

EmailWire is a press release distribution service of GroupWeb Media LLC.

© Copyright GroupWeb Media LLC 2012